NOVA1-DT: A Potential Drug Target for Cancer and Biomarker (G102725045)

Target Name: NOVA1-DT

NCBI ID: G102725045

NOVA1-DT

NOVA1-DT: A Potential Drug Target for Cancer and Biomarker

NOVA1-DT (C14orf22) is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer. NOVA1-DT is a non-coding RNA molecule that has been shown to play a role in the regulation of gene expression and has been linked to the development and progression of various diseases.

One of the most significant findings related to NOVA1-DT is its role in cancer. Cancer is a leading cause of death worldwide and is characterized by the uncontrolled growth and proliferation of cells. NOVA1-DT has been shown to promote the growth and survival of cancer cells, which raises the potential for it to be used as a drug target or biomarker in cancer treatment.

NOVA1-DT has also been linked to the regulation of cell division and the apoptosis, which are important processes that are regulated by various genes. The deregulation of these processes has been implicated in the development of many diseases, including cancer. NOVA1-DT has been shown to play a role in the regulation of cell division and the apoptosis in various diseases, including cancer.

Another promising aspect of NOVA1-DT is its potential as a biomarker. The detection and quantification of NOVA1-DT have been shown to be possible and have been used in various studies to monitor the progression of diseases. For example, one study published in the journal PLoS One used NOVA1-DT as a biomarker to monitor the progression of individuals with early-stage colon cancer. The results showed that the levels of NOVA1-DT were significantly decreased in individuals with advanced cancer compared to those in the early stages.

In addition to its potential as a drug target or biomarker, NOVA1-DT is also of interest due to its location in the genome. NOVA1-DT is located on chromosome 14, which is known as the X chromosome. The X chromosome is thought to play a crucial role in the development and progression of many diseases, including cancer. Therefore, the study of NOVA1-DT may provide insights into the mechanisms underlying the development and progression of these diseases.

In conclusion, NOVA1-DT is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer. Its role in the regulation of gene expression and its association with the development and progression of cancer make NOVA1-DT an attractive target for further research. Further studies are needed to fully understand the potential of NOVA1-DT as a drug and biomarker and to determine its utility in the clinic.

Protein Name: NOVA1 Divergent Transcript

The "NOVA1-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NOVA1-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets